Michelle L O'Donoghue Selected Research

Michelle L O'Donoghue Research Topics

Disease

30	Myocardial Infarction 01/2022 - 05/2011
20	Acute Coronary Syndrome 01/2022 - 09/2009
13	Hemorrhage 12/2022 - 05/2011
10	Stroke (Strokes) 01/2021 - 05/2011
10	Atherosclerosis 04/2019 - 09/2011
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2011
7	Inflammation (Inflammations) 01/2022 - 07/2012
7	Heart Failure 01/2021 - 09/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 05/2011
5	Atrial Fibrillation 01/2021 - 06/2015
4	ST Elevation Myocardial Infarction 01/2022 - 05/2015
4	Ischemia 01/2022 - 05/2011
4	Obesity 07/2019 - 01/2018
4	Thrombosis (Thrombus) 01/2019 - 12/2014
3	Hypertension (High Blood Pressure) 01/2021 - 01/2018
3	Diabetes Mellitus 01/2021 - 08/2013
3	Fibrosis (Cirrhosis) 11/2018 - 10/2012
2	Venous Thromboembolism 01/2022 - 01/2020
2	Pulmonary Embolism 01/2022 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	Ischemic Stroke 04/2021 - 01/2021
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 12/2013
2	Coronary Disease (Coronary Heart Disease) 01/2019 - 01/2017
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 12/2013
2	Unstable Angina 05/2011 - 05/2011
1	Renal Insufficiency (Renal Failure) 01/2022
1	Non-ST Elevated Myocardial Infarction 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Hemorrhagic Stroke 01/2021
1	Ventricular Tachycardia 01/2021
1	Injection Site Reaction 01/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020
1	Genetic Risk Score 01/2020
1	Osteoporosis 12/2019
1	Bone Resorption 12/2019
1	Hip Fractures (Intertrochanteric Fractures) 12/2019

Drug/Important Bio-Agent (IBA)

10	darapladibIBA 01/2021 - 10/2011
8	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2018 - 09/2011
8	Clopidogrel (Plavix)FDA Link 01/2016 - 09/2009
6	omega-Chloroacetophenone (Mace)IBA 01/2022 - 04/2019
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 08/2013
5	C-Reactive ProteinIBA 01/2022 - 09/2011
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2012
4	Lipoprotein(a)IBA 01/2022 - 08/2013
4	evolocumabIBA 01/2021 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2018
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022 - 12/2014
3	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 05/2015
3	6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA 01/2022 - 05/2015
3	oxidized low density lipoproteinIBA 01/2022 - 08/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2019
3	Proprotein Convertase 9IBA 01/2020 - 08/2013
3	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2017 - 09/2011
3	E 5555IBA 07/2012 - 05/2011
2	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2016
2	CytokinesIBA 01/2022 - 10/2017
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022 - 01/2018
2	LipidsIBA 01/2021 - 08/2013
2	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 06/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 01/2021
2	edoxabanIBA 01/2021 - 06/2015
2	vorapaxarIBA 04/2019 - 12/2014
2	LDL CholesterolIBA 01/2019 - 08/2013
2	Troponin IIBA 01/2018 - 10/2017
2	EnzymesIBA 01/2018 - 12/2013
2	Natriuretic PeptidesIBA 01/2018 - 01/2016
2	Troponin T (Troponin T1)IBA 01/2016 - 09/2011
2	Galectin 3 (LGALS3)IBA 01/2016 - 10/2012
2	Atorvastatin (Lipitor)FDA Link 05/2014 - 12/2013
2	Secretory Phospholipases A2IBA 03/2014 - 09/2011
2	Prasugrel Hydrochloride FDA Link 12/2013 - 09/2009
2	Thrombin FDA Link 05/2011 - 05/2011
1	Pharmaceutical PreparationsIBA 01/2022
1	Exenatide (Byetta)FDA Link 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	MitogensIBA 01/2022
1	CeramidesIBA 01/2022
1	Eicosapentaenoic AcidIBA 01/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021
1	Ranolazine FDA Link 01/2021
1	docosapentaenoic acidIBA 01/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	saxagliptin FDA Link 01/2021
1	Neurofibromin 2 (Merlin)IBA 01/2021
1	dapagliflozinIBA 01/2021
1	Docosahexaenoic AcidsIBA 01/2021
1	alpha-Linolenic Acid (Linolenic Acid)IBA 01/2021
1	TicagrelorIBA 01/2021
1	SmokeIBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	CholesterolIBA 01/2020
1	alirocumabIBA 01/2020

Therapy/Procedure

13	Therapeutics 04/2022 - 05/2011
5	Stents 04/2022 - 12/2014
4	Percutaneous Coronary Intervention 04/2022 - 12/2013
2	Secondary Prevention 11/2018 - 12/2014
1	Subcutaneous Infusions 01/2022
1	Transplantation 01/2022